Replies to post #1565 on GG&G

[2Relax]

I have been here a long time, and cannot remember this company ever being in this position. The best since I’ve owned it.

UK NHS & surprise B Braun day surgery announcements were both HUGE. They will both get more cranked up and just using those two new revenue streams combined with our existing sales will put us over what we did the entire year in 2017.

The UK says 26,000,000 people visit doctors for chronic pain.

We know this product works EXTREMELY WELL. Add this going forward on an annual basis:

(NHS patients using Actipatch 2018)

1 out of 100 (1%) = 260,000 units

1 out of 20 (5%) = 1.3M units sold

1 out of 10 (10%) = 2.6M units sold

Germany, France, Spain will follow the UK NHS program IMO. Then the USA will finally get FHA approval for clearance on the Back and musculoskeletal pain. When that happens the box stores will open up immediately in the USA. In my opinion, because of the great news out of the UK, the FHA Clearance will happen by summer with any luck.

If we see sales in excess of $5M in Q2... that would be the major part of this going through roof this year.

I am just enjoying the fact that I own shares... GLTA invested!!!